Biomarkers

Aims & Scope

The journal Biomarkers brings together all aspects of the rapidly growing field of biomarker research, encompassing their various uses and applications in one essential source.

Biomarkers provides a vital forum for the exchange of ideas and concepts in all areas of biomarker research.

High quality papers in four main areas are accepted and manuscripts describing novel biomarkers and their subsequent validation are especially encouraged: • Biomarkers of disease • Biomarkers of exposure • Biomarkers of response • Biomarkers of susceptibility Manuscripts can describe biomarkers measured in humans or other animals in vivo or in vitro.

Biomarkers will consider publishing negative data from studies of biomarkers of susceptibility in human populations.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.9
2024	2.00

SJR (SCImago Journal Rank)

Year	Value
2024	0.500

Quartile

Year	Value
2024	Q3

Journal Rank

Year	Value
2024	11595

Journal Citation Indicator

Year	Value
2024	525

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Environmental Science and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Glutathione levels in human tumors

  Citation: 501

  Authors: Michael P., Mohit S., Stephanie D., O. Michael

• Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis

  Citation: 391

  Authors: John C., Elaine, Mary E., Elizabeth G., Jeremy K.

• Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer

  Citation: 303

  Authors: Hyuk-Chan, Sung Hyun, Sung Yong, Suee, Ji Hyun, Hong-Jo, Ki-Jae, Mee Sook, Seung-Geun, Hyo-Jin, Jong Hoon

• F₂-Isoprostanes as markers of oxidative stress<i>in vivo</i>: An overview

  Citation: 247

  Authors: Ginger L., Erik S., Jason D.

• The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases

  Citation: 220

  Authors: Vanessa, Morena, Javier, Rodolfo, Ana, Jesús, Juan J., Francisca, Ali, Oreste

• Biomarkers of some pulmonary diseases in exhaled breath

  Citation: 212

  Authors: Sergei A., Peter J.

• Do metals inhibit acetylcholinesterase (AChE)? Implementation of assay conditions for the use of AChE activity as a biomarker of metal toxicity

  Citation: 209

  Authors: M. F., D., F., L.

• SHORT COMMUNICATION Should the use of inhibition of cholinesterases as a specific biomarker for organophosphate and carbamate pesticides be questioned

  Citation: 190

  Authors: LUCIA, PIEDADE, M. C., AMADEU M. V. M.

• Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass

  Citation: 187

  Authors: Orfeas, Hocine, Mary C., Alexey, Won K., Ron, Joseph V., Bertrand L.

• Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer

  Citation: 187

  Authors: Xin, Pei-Rong, Yu-Hong, Feng-Hua, Yan-Xia, Zhi-Qiang, You-Jian, Rui-Hua, Wen-Qi

---